SE411627B - Analogiforfarande for framstellning av bicykliska imidazoler och pyrimidiner - Google Patents

Analogiforfarande for framstellning av bicykliska imidazoler och pyrimidiner

Info

Publication number
SE411627B
SE411627B SE7316354A SE7316354A SE411627B SE 411627 B SE411627 B SE 411627B SE 7316354 A SE7316354 A SE 7316354A SE 7316354 A SE7316354 A SE 7316354A SE 411627 B SE411627 B SE 411627B
Authority
SE
Sweden
Prior art keywords
pyrimidines
preparation
analogy procedure
imidazoles
bicyclic
Prior art date
Application number
SE7316354A
Other languages
English (en)
Swedish (sv)
Inventor
Gelder J L H Van
Leerhoven W J Van
A H M Raeymaekers
L F C Roevens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SE411627B publication Critical patent/SE411627B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/42Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/48Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12Nitrogen atoms not forming part of a nitro radical
    • C07D239/14Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7316354A 1972-12-08 1973-12-04 Analogiforfarande for framstellning av bicykliska imidazoler och pyrimidiner SE411627B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US313285A US3865836A (en) 1972-12-08 1972-12-08 Bicyclic imidazoles

Publications (1)

Publication Number Publication Date
SE411627B true SE411627B (sv) 1980-01-21

Family

ID=23215116

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7316354A SE411627B (sv) 1972-12-08 1973-12-04 Analogiforfarande for framstellning av bicykliska imidazoler och pyrimidiner

Country Status (23)

Country Link
US (1) US3865836A (US06826419-20041130-M00005.png)
JP (1) JPS4994694A (US06826419-20041130-M00005.png)
AT (1) AT333770B (US06826419-20041130-M00005.png)
BE (1) BE808416A (US06826419-20041130-M00005.png)
BG (1) BG21608A3 (US06826419-20041130-M00005.png)
CA (1) CA1010864A (US06826419-20041130-M00005.png)
CH (1) CH593975A5 (US06826419-20041130-M00005.png)
DE (1) DE2361188A1 (US06826419-20041130-M00005.png)
DK (1) DK141289B (US06826419-20041130-M00005.png)
FI (1) FI54711C (US06826419-20041130-M00005.png)
FR (1) FR2209576B1 (US06826419-20041130-M00005.png)
GB (1) GB1446482A (US06826419-20041130-M00005.png)
HU (1) HU168638B (US06826419-20041130-M00005.png)
IE (1) IE38618B1 (US06826419-20041130-M00005.png)
IL (1) IL43770A (US06826419-20041130-M00005.png)
NL (1) NL7316778A (US06826419-20041130-M00005.png)
NO (1) NO139087C (US06826419-20041130-M00005.png)
PH (1) PH10417A (US06826419-20041130-M00005.png)
PL (1) PL94683B1 (US06826419-20041130-M00005.png)
RO (1) RO63263A (US06826419-20041130-M00005.png)
SE (1) SE411627B (US06826419-20041130-M00005.png)
SU (1) SU578003A3 (US06826419-20041130-M00005.png)
ZA (1) ZA739343B (US06826419-20041130-M00005.png)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181927B (en) * 1977-07-06 1983-11-28 Iso Pharmachim Process for producing r,s-2,3,5,6-tetrahydro-6-phenyl-imidazo-bracket-2,1-b-bracket closed thiazol /tetramizol/
BG25138A1 (en) * 1977-07-06 1978-08-10 Georgiev A method of obtaining of rs-(+/-)-2,3,5,6-tetrahydro-6-phenylimidazo-(2,1-b)-thiazol(tetramizol)
DE2827617A1 (de) * 1978-06-23 1980-01-10 Boehringer Sohn Ingelheim Neue imidazo eckige klammer auf 1,2- alpha eckige klammer zu imidazole, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
US4370500A (en) * 1978-11-06 1983-01-25 American Cyanamid Company Compound: d-N-(2-amino-2-phenethyl)-2-methoxyethylamine and process for preparing the same by selective crystallization
DE3042636A1 (de) * 1980-11-12 1982-06-16 C.H. Boehringer Sohn, 6507 Ingelheim Neue 7-(2,6-dibrom-4-methylphenyl)-2,3-dihydro-imidazo(1,2-a)imidazole, deren saeureadditionssalze, diese enhthaltende arzneimittel und verfahren zu deren herstellung
GB8509531D0 (en) * 1985-04-13 1985-05-15 Bp Chem Int Ltd Preparation of guanidines
US6359144B1 (en) * 1997-02-04 2002-03-19 Lion Bioscience Ag Combinatorial libraries of bicyclic guanidine derivatives and compounds therein
MXPA03006484A (es) * 2001-01-26 2003-09-22 Bristol Myers Squibb Co Derivados de imidazolilo como inhibidores del factor de liberacion de corticotropina.
NZ531244A (en) * 2001-09-21 2006-06-30 Sanofi Aventis Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders
JP2008543840A (ja) * 2005-06-14 2008-12-04 シェーリング コーポレイション アスパルチルプロテアーゼインヒビター
US8563560B2 (en) * 2011-02-25 2013-10-22 Ppg Industries Ohio, Inc. Preparation of bicyclic guanidine salts in an aqueous media

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB796996A (en) * 1956-03-29 1958-06-25 Monsanto Canada Ltd Imidazole derivatives
GB805877A (en) * 1957-01-28 1958-12-17 Monsanto Canada Ltd Process for the production of 2, 3, 5, 6-tetrahydro-1-imidaz (1, 2-a) imidazole

Also Published As

Publication number Publication date
FI54711B (fi) 1978-10-31
PL94683B1 (pl) 1977-08-31
PH10417A (en) 1977-03-16
CA1010864A (en) 1977-05-24
RO63263A (fr) 1978-08-15
IL43770A0 (en) 1974-03-14
IL43770A (en) 1976-08-31
ZA739343B (en) 1975-07-30
IE38618L (en) 1974-06-08
HU168638B (US06826419-20041130-M00005.png) 1976-06-28
SU578003A3 (ru) 1977-10-25
IE38618B1 (en) 1978-04-26
FR2209576A1 (US06826419-20041130-M00005.png) 1974-07-05
GB1446482A (en) 1976-08-18
DE2361188A1 (de) 1974-06-12
BG21608A3 (US06826419-20041130-M00005.png) 1976-07-20
NO139087B (no) 1978-09-25
CH593975A5 (US06826419-20041130-M00005.png) 1977-12-30
DK141289C (US06826419-20041130-M00005.png) 1980-08-11
NO139087C (no) 1979-01-03
FI54711C (fi) 1979-02-12
US3865836A (en) 1975-02-11
NL7316778A (US06826419-20041130-M00005.png) 1974-06-11
FR2209576B1 (US06826419-20041130-M00005.png) 1977-01-28
AT333770B (de) 1976-12-10
AU6337173A (en) 1975-06-12
BE808416A (fr) 1974-06-10
DK141289B (da) 1980-02-18
ATA1026573A (de) 1976-04-15
JPS4994694A (US06826419-20041130-M00005.png) 1974-09-09

Similar Documents

Publication Publication Date Title
NO793012L (no) Fremgangsmaate ved fremstilling av benzodiazepinderivater
NO140556C (no) Fremgangsmaate for fremstilling av n-fosfonometyl-glycin
SE414497B (sv) Forfarande for framstellning av p-karbonyloxim-fenoxialkyl-karboxamider
FI54067C (fi) Foerfarande och anordning foer reglering av vaermeavgaongen i kokiller vid straenggjutning
SE7604260L (sv) Forfarande for isolering av ap-glykoproteiner
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE411627B (sv) Analogiforfarande for framstellning av bicykliska imidazoler och pyrimidiner
NO140478C (no) Fremgangsmaate for fremstilling av fibriller
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE416176B (sv) Forfarande for framstellning av hogdoserade autibiotikatabletter
SE399425B (sv) Forfarande for framstellning av 1-fenoxi-3-aminopropan-2-ol-derivat
SE7511680L (sv) Forfarande for framstellning av furanderivat
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE418197B (sv) Forfarande och enzymkomplex for framstellning av 6-aminopenicillansyra
FI56670B (fi) Foerfarande foer framstaellning av 5-cyklohexyl-6-halogenindan-1-karboxylsyraderivat
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
NO139086C (no) R fremgangsmaate for fremstilling av benzensulfonylurinstoffe
NO148849C (no) Analogifremgangsmaate for fremstilling av krystallinsk pivaloyloksymetyl-d-(-)-alfa-aminobenzylpenicillinat
SE413510B (sv) Analogiforfarande for framstellning av n-(furyl- och tienylmetyl)-desoxi-normorfiner och norkodeiner